Clinical Trial: Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093008) titled 'Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation' on July 04.

Brief Summary: This is a Phase 1, investigator- and participant-blinded, placebo-controlled, randomized, crossover study to compare bioavailability of AQ280 following single oral doses of a capsule formulation versus a tablet for oral suspension formulation in healthy participants.

Study Start Date: June 13

Study Type: INTERVENTIONAL

Condition: Eosinophilic Esophagitis

Intervention: DRUG: AQ280 Capsule

AQ280 administered orally in capsule formulation. ...